EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

‘Vital’ UK remains part of EU clinical trials, say MPs

Continued participation in EU-wide clinical trials and the Horizon 2020 research programme is ‘vital’ to the UK’s life sciences sector, according to a new cross-par...
Continue Reading →
Europe

Patients Regain Sight With Stem Cell Treatment In U.K. Clinical Trial

Nearly three years ago, 86-year-old Douglas Waters developed severe vision problems. He was diagnosed with severe wet age-related macular degeneration(AMD), a chroni...
Continue Reading →
Europe

Brexit boom ahead for Dutch clinical trials and human test subjects

The arrival of the European Medicines Agency in Amsterdam next year will be a major boost for the Netherlands’ own drugs testing sector, and moves are already being ...
Continue Reading →
news

Domain Therapeutics’ innovative business model gains validation through Prexton Therapeutics’ acquisition by Lundbeck for up to $1.1 billion

Domain Therapeutics to receive up to $125 million for assignment of its intellectual property covering the Foliglurax mGluR4 PAM series discovered by the French biote...
Continue Reading →
news

Brain Healthcare Innovator ElMindA Adopting Smart Data

Pilots MEDEI's SMART-TRIAL data management platform to better document the efficacy and safety of its brain network activation technology One of the world's leading...
Continue Reading →
news

Chief Medical Officer Robert Kleiman, MD, to receive Big Heart Award by Simon’s Fund

A global data and technology company that minimizes uncertainty and risk in clinical trials, today announced that it has been recognized by Simon’s Fund with a Big He...
Continue Reading →
Europe

Proteomics launches diagnostic test leader ‘PromarkerD’

Proteomics International is engaged with potential partners to bring PromarkerD to market in mainland USA, Mexico, Japan, Australia, China and Europe. MedTech pione...
Continue Reading →
Europe

MHRA Grants UK Patients Early Access to Akcea Therapeutics’ Volanesorsen for Familial Chylomicronaemia Syndrome (FCS)

Akcea Therapeutics United Kingdom (UK) Ltd today announced that volanesorsen has been granted a positive scientific opinion through the Early Access to Medicines Sche...
Continue Reading →
Europe

Citoxlab acquires Solvo Biotechnology, the leading CRO specializing in drug transporter research and Drug-Drug Interactions

With this acquisition, Citoxlab reinforces its leadership position among the top five non-clinical CROs Citoxlab Group, a leading player among non-clinical CROs, anno...
Continue Reading →
Europe

Four Medicen Paris Region members selected for the European SME Instrument program

As part of phase 2 of the EU Horizon 2020 R&D program, healthcare-focused SMEs will receive funding of €1-3M ($1.2-3.7M) for a period of 12 to 24 months Medicen P...
Continue Reading →
Quotient